GGrantIndex
← Leaderboards

Alexander George Rabchevsky

University Of Kentucky

$3,637,021
Attributed
$5,200,318
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $453.9K · FY200522
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$5,200,318 · 5

By mechanism

R01$4,372,568 · 3
R21$827,750 · 2

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Others in their field

Top investigators on “Spinal Cord Injury

Research focus

Spinal Cord InjuryRattusInjuryCellsBaseSiteAcuteNeuronsMitochondriaTissuesHomeostasisDosageRecovery Of FunctionNeuroprotectionDesignDoseBioenergeticsInnovationSpinal CordResponseMaintenanceCombinatorialCell CountGlutathione

Grant awards (17)

Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery$449,945
R01 · FY2022 · NS · contact PI
Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery$449,945
R01 · FY2021 · NS · contact PI
Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery$453,894
R01 · FY2020 · NS · contact PI
Changing serotonin receptor 2C splice variants to combat spasticity after spinal cord injury$188,125
R21 · FY2018 · NS
Changing serotonin receptor 2C splice variants to combat spasticity after spinal cord injury$225,750
R21 · FY2017 · NS
Mitochondrial Transplantation Strategies to Promote Recovery after Spinal Cord Injury$188,125
R21 · FY2017 · NS · contact PI
Mitochondrial Transplantation Strategies to Promote Recovery after Spinal Cord Injury$225,750
R21 · FY2016 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$321,596
R01 · FY2014 · NS
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$313,474
R01 · FY2013 · NS
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$74,177
R01 · FY2013 · NS
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$324,844
R01 · FY2012 · NS
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$324,844
R01 · FY2011 · NS
Role of Intraspinal Plasticity in Autonomic Dysreflexia$322,980
R01 · FY2008 · NS · contact PI
Role of Intraspinal Plasticity in Autonomic Dysreflexia$322,980
R01 · FY2007 · NS · contact PI
Role of Intraspinal Plasticity in Autonomic Dysreflexia$332,627
R01 · FY2006 · NS · contact PI
Role of Intraspinal Plasticity in Autonomic Dysreflexia$340,631
R01 · FY2005 · NS
Role of Intraspinal Plasticity in Autonomic Dysreflexia$340,631
R01 · FY2004 · NS